Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
235 SEK | +2.17% | -3.29% | +10.85% |
Apr. 25 | Transcript : CellaVision AB, Q1 2024 Earnings Call, Apr 25, 2024 | |
Apr. 25 | CellaVision AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2024 * | 782M 73.03M | Sales 2025 * | 889M 82.94M | Capitalization | 5.61B 523M |
---|---|---|---|---|---|
Net income 2024 * | 172M 16.05M | Net income 2025 * | 217M 20.25M | EV / Sales 2024 * | 6.99 x |
Net cash position 2024 * | 138M 12.85M | Net cash position 2025 * | 212M 19.81M | EV / Sales 2025 * | 6.07 x |
P/E ratio 2024 * |
32.7
x | P/E ratio 2025 * |
25.8
x | Employees | - |
Yield 2024 * |
1.05% | Yield 2025 * |
1.28% | Free-Float | 82.65% |
Latest transcript on CellaVision AB
1 day | +2.17% | ||
1 week | -3.29% | ||
Current month | +4.21% | ||
1 month | +7.55% | ||
3 months | -12.48% | ||
6 months | +40.55% | ||
Current year | +10.85% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 59 | 94-11-15 | |
Simon Ostergaard
CEO | Chief Executive Officer | 53 | 21-03-20 |
Magnus Blixt
DFI | Director of Finance/CFO | 58 | 13-05-01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 59 | 94-11-15 | |
Lotta Jarleryd
BRD | Director/Board Member | 58 | 22-05-10 |
Mikael Worning
CHM | Chairman | 62 | 20-04-22 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 235 | +2.17% | 12,316 |
24-05-16 | 230 | -0.43% | 11,425 |
24-05-15 | 231 | +0.65% | 5,696 |
24-05-14 | 229.5 | -0.43% | 11,783 |
24-05-13 | 230.5 | -5.14% | 10,700 |
Delayed Quote Nasdaq Stockholm, May 17, 2024 at 11:29 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.85% | 523M | |
-19.42% | 18.12B | |
-41.90% | 2.87B | |
+19.36% | 1.9B | |
-1.05% | 1.65B | |
+33.96% | 1.34B | |
-16.83% | 957M | |
-21.96% | 896M | |
+7.07% | 841M | |
-26.98% | 612M |
- Stock Market
- Equities
- CEVI Stock